Serveur d'exploration Chloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Treatment Algorithms for Systemic Sclerosis According to Experts.

Identifieur interne : 000C10 ( Main/Exploration ); précédent : 000C09; suivant : 000C11

Treatment Algorithms for Systemic Sclerosis According to Experts.

Auteurs : Andreu Fernández-Codina [Espagne] ; Kyle M. Walker [Canada] ; Janet E. Pope [Canada]

Source :

RBID : pubmed:29781586

Descripteurs français

English descriptors

Abstract

There is a lack of agreement regarding treatment for many aspects of systemic sclerosis (SSc). We undertook this study to generate SSc treatment algorithms endorsed by a high percentage of SSc experts.

DOI: 10.1002/art.40560
PubMed: 29781586


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Treatment Algorithms for Systemic Sclerosis According to Experts.</title>
<author>
<name sortKey="Fernandez Codina, Andreu" sort="Fernandez Codina, Andreu" uniqKey="Fernandez Codina A" first="Andreu" last="Fernández-Codina">Andreu Fernández-Codina</name>
<affiliation wicri:level="3">
<nlm:affiliation>University of Western Ontario, London, Ontario, Canada, and Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>University of Western Ontario, London, Ontario, Canada, and Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona</wicri:regionArea>
<placeName>
<settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Walker, Kyle M" sort="Walker, Kyle M" uniqKey="Walker K" first="Kyle M" last="Walker">Kyle M. Walker</name>
<affiliation wicri:level="1">
<nlm:affiliation>The Ottawa Hospital, University of Ottawa, Ottawa, Ontario, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>The Ottawa Hospital, University of Ottawa, Ottawa, Ontario</wicri:regionArea>
<wicri:noRegion>Ontario</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Pope, Janet E" sort="Pope, Janet E" uniqKey="Pope J" first="Janet E" last="Pope">Janet E. Pope</name>
<affiliation wicri:level="1">
<nlm:affiliation>University of Western Ontario, London, Ontario, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>University of Western Ontario, London, Ontario</wicri:regionArea>
<wicri:noRegion>Ontario</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2018">2018</date>
<idno type="RBID">pubmed:29781586</idno>
<idno type="pmid">29781586</idno>
<idno type="doi">10.1002/art.40560</idno>
<idno type="wicri:Area/PubMed/Corpus">000107</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000107</idno>
<idno type="wicri:Area/PubMed/Curation">000107</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000107</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000083</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000083</idno>
<idno type="wicri:Area/Ncbi/Merge">000446</idno>
<idno type="wicri:Area/Ncbi/Curation">000446</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000446</idno>
<idno type="wicri:Area/Main/Merge">000C10</idno>
<idno type="wicri:Area/Main/Curation">000C10</idno>
<idno type="wicri:Area/Main/Exploration">000C10</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Treatment Algorithms for Systemic Sclerosis According to Experts.</title>
<author>
<name sortKey="Fernandez Codina, Andreu" sort="Fernandez Codina, Andreu" uniqKey="Fernandez Codina A" first="Andreu" last="Fernández-Codina">Andreu Fernández-Codina</name>
<affiliation wicri:level="3">
<nlm:affiliation>University of Western Ontario, London, Ontario, Canada, and Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>University of Western Ontario, London, Ontario, Canada, and Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona</wicri:regionArea>
<placeName>
<settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Walker, Kyle M" sort="Walker, Kyle M" uniqKey="Walker K" first="Kyle M" last="Walker">Kyle M. Walker</name>
<affiliation wicri:level="1">
<nlm:affiliation>The Ottawa Hospital, University of Ottawa, Ottawa, Ontario, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>The Ottawa Hospital, University of Ottawa, Ottawa, Ontario</wicri:regionArea>
<wicri:noRegion>Ontario</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Pope, Janet E" sort="Pope, Janet E" uniqKey="Pope J" first="Janet E" last="Pope">Janet E. Pope</name>
<affiliation wicri:level="1">
<nlm:affiliation>University of Western Ontario, London, Ontario, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>University of Western Ontario, London, Ontario</wicri:regionArea>
<wicri:noRegion>Ontario</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Arthritis & rheumatology (Hoboken, N.J.)</title>
<idno type="eISSN">2326-5205</idno>
<imprint>
<date when="2018" type="published">2018</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Algorithms</term>
<term>Angiotensin Receptor Antagonists (therapeutic use)</term>
<term>Angiotensin-Converting Enzyme Inhibitors (therapeutic use)</term>
<term>Antibodies, Monoclonal, Humanized (therapeutic use)</term>
<term>Antirheumatic Agents (therapeutic use)</term>
<term>Arthritis (drug therapy)</term>
<term>Arthritis (etiology)</term>
<term>Calcium Channels (therapeutic use)</term>
<term>Cyclophosphamide (therapeutic use)</term>
<term>Endothelin Receptor Antagonists (therapeutic use)</term>
<term>Glucocorticoids (therapeutic use)</term>
<term>Humans</term>
<term>Hydroxychloroquine</term>
<term>Hypertension, Pulmonary (drug therapy)</term>
<term>Hypertension, Pulmonary (etiology)</term>
<term>Immunosuppressive Agents (therapeutic use)</term>
<term>Kidney Diseases (drug therapy)</term>
<term>Kidney Diseases (etiology)</term>
<term>Lung Diseases, Interstitial (drug therapy)</term>
<term>Lung Diseases, Interstitial (etiology)</term>
<term>Methotrexate (therapeutic use)</term>
<term>Mycophenolic Acid (therapeutic use)</term>
<term>Phosphodiesterase 5 Inhibitors (therapeutic use)</term>
<term>Prostaglandins (therapeutic use)</term>
<term>Raynaud Disease (drug therapy)</term>
<term>Raynaud Disease (etiology)</term>
<term>Rituximab (therapeutic use)</term>
<term>Scleroderma, Systemic (complications)</term>
<term>Scleroderma, Systemic (drug therapy)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Acide mycophénolique (usage thérapeutique)</term>
<term>Algorithmes</term>
<term>Antagonistes des récepteurs aux angiotensines (usage thérapeutique)</term>
<term>Antagonistes des récepteurs de l'endothéline (usage thérapeutique)</term>
<term>Anticorps monoclonaux humanisés (usage thérapeutique)</term>
<term>Antirhumatismaux (usage thérapeutique)</term>
<term>Arthrite (traitement médicamenteux)</term>
<term>Arthrite (étiologie)</term>
<term>Canaux calciques (usage thérapeutique)</term>
<term>Cyclophosphamide (usage thérapeutique)</term>
<term>Glucocorticoïdes (usage thérapeutique)</term>
<term>Humains</term>
<term>Hydroxychloroquine</term>
<term>Hypertension pulmonaire (traitement médicamenteux)</term>
<term>Hypertension pulmonaire (étiologie)</term>
<term>Immunosuppresseurs (usage thérapeutique)</term>
<term>Inhibiteurs de l'enzyme de conversion de l'angiotensine (usage thérapeutique)</term>
<term>Inhibiteurs de la phosphodiestérase-5 (usage thérapeutique)</term>
<term>Maladie de Raynaud (traitement médicamenteux)</term>
<term>Maladie de Raynaud (étiologie)</term>
<term>Maladies du rein (traitement médicamenteux)</term>
<term>Maladies du rein (étiologie)</term>
<term>Méthotrexate (usage thérapeutique)</term>
<term>Pneumopathies interstitielles (traitement médicamenteux)</term>
<term>Pneumopathies interstitielles (étiologie)</term>
<term>Prostaglandines (usage thérapeutique)</term>
<term>Rituximab (usage thérapeutique)</term>
<term>Sclérodermie systémique ()</term>
<term>Sclérodermie systémique (traitement médicamenteux)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Angiotensin Receptor Antagonists</term>
<term>Angiotensin-Converting Enzyme Inhibitors</term>
<term>Antibodies, Monoclonal, Humanized</term>
<term>Antirheumatic Agents</term>
<term>Calcium Channels</term>
<term>Cyclophosphamide</term>
<term>Endothelin Receptor Antagonists</term>
<term>Glucocorticoids</term>
<term>Immunosuppressive Agents</term>
<term>Methotrexate</term>
<term>Mycophenolic Acid</term>
<term>Phosphodiesterase 5 Inhibitors</term>
<term>Prostaglandins</term>
<term>Rituximab</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en">
<term>Scleroderma, Systemic</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Arthritis</term>
<term>Hypertension, Pulmonary</term>
<term>Kidney Diseases</term>
<term>Lung Diseases, Interstitial</term>
<term>Raynaud Disease</term>
<term>Scleroderma, Systemic</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en">
<term>Arthritis</term>
<term>Hypertension, Pulmonary</term>
<term>Kidney Diseases</term>
<term>Lung Diseases, Interstitial</term>
<term>Raynaud Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr">
<term>Arthrite</term>
<term>Hypertension pulmonaire</term>
<term>Maladie de Raynaud</term>
<term>Maladies du rein</term>
<term>Pneumopathies interstitielles</term>
<term>Sclérodermie systémique</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr">
<term>Acide mycophénolique</term>
<term>Antagonistes des récepteurs aux angiotensines</term>
<term>Antagonistes des récepteurs de l'endothéline</term>
<term>Anticorps monoclonaux humanisés</term>
<term>Antirhumatismaux</term>
<term>Canaux calciques</term>
<term>Cyclophosphamide</term>
<term>Glucocorticoïdes</term>
<term>Immunosuppresseurs</term>
<term>Inhibiteurs de l'enzyme de conversion de l'angiotensine</term>
<term>Inhibiteurs de la phosphodiestérase-5</term>
<term>Méthotrexate</term>
<term>Prostaglandines</term>
<term>Rituximab</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr">
<term>Arthrite</term>
<term>Hypertension pulmonaire</term>
<term>Maladie de Raynaud</term>
<term>Maladies du rein</term>
<term>Pneumopathies interstitielles</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Algorithms</term>
<term>Humans</term>
<term>Hydroxychloroquine</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Algorithmes</term>
<term>Humains</term>
<term>Hydroxychloroquine</term>
<term>Sclérodermie systémique</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">There is a lack of agreement regarding treatment for many aspects of systemic sclerosis (SSc). We undertook this study to generate SSc treatment algorithms endorsed by a high percentage of SSc experts.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Canada</li>
<li>Espagne</li>
</country>
<region>
<li>Catalogne</li>
</region>
<settlement>
<li>Barcelone</li>
</settlement>
</list>
<tree>
<country name="Espagne">
<region name="Catalogne">
<name sortKey="Fernandez Codina, Andreu" sort="Fernandez Codina, Andreu" uniqKey="Fernandez Codina A" first="Andreu" last="Fernández-Codina">Andreu Fernández-Codina</name>
</region>
</country>
<country name="Canada">
<noRegion>
<name sortKey="Walker, Kyle M" sort="Walker, Kyle M" uniqKey="Walker K" first="Kyle M" last="Walker">Kyle M. Walker</name>
</noRegion>
<name sortKey="Pope, Janet E" sort="Pope, Janet E" uniqKey="Pope J" first="Janet E" last="Pope">Janet E. Pope</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000C10 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000C10 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:29781586
   |texte=   Treatment Algorithms for Systemic Sclerosis According to Experts.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:29781586" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a ChloroquineV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021